Published in Clinical Trials Arena, this article examines how Australia and South Korea are addressing key bottlenecks in radiopharmaceutical clinical trials. Novotech’s Stacy Lee outlines how faster regulatory pathways, diversified supply networks, and multi-region trial strategies can reduce startup delays and support time-sensitive radiopharma studies. 

Read the full article